BF
MDGL icon

BOK Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

BOK Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$908 – 1162
2025
Q2 		$908 Hold
3
– – ﹤0.01% 1088
2025
Q1 		$994 Hold
3
– – ﹤0.01% 1176
2024
Q4 		$1.02K Sell
3
-7
-70% -$1.97K ﹤0.01% 1191
2024
Q3 		$2.07K Buy
+10
New +$2.56K ﹤0.01% 1143
2024
Q2 		– Sell
-10
Closed -$2.56K – 1228
2024
Q1 		$2.56K Hold
10
– – ﹤0.01% 1044
2023
Q4 		$2.31K Buy
+10
New +$1.75K ﹤0.01% 1094

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BOK Financial's MDGL Position: Q3 2025 in Review

BOK Financial sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2025, closing a stake of 3 shares — an estimated $908 sold.

BOK Financial first reported a position in MDGL in Q4 2023 and held it in 6 quarters. The position peaked at $2.56K in Q1 2024. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • BOK Financial reported no remaining Madrigal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • BOK Financial sold 3 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $908.
  • BOK Financial first reported a position in Madrigal Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • BOK Financial's Madrigal Pharmaceuticals position peaked at $2.56K in Q1 2024.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on BOK Financial's 13F filing for Q3 2025, filed 13 Nov 2025.